Alumis ALMS
NASDAQ ALMS
$6.80 -0.01 (-0.15%)
As of: Oct 22, 2026 · 2:34 PM EDT

Alumis (ALMS) Non-Current Deffered Revenue (2025)

Updated

Alumis (ALMS) reported Non-Current Deffered Revenue of $2.61 million for Q4 2025, up 34.3% from the prior quarter.

Analysis

Alumis (ALMS) Non-Current Deffered Revenue (2025) Analysis & Trends

Dating back to Q1 2025, Alumis' Non-Current Deffered Revenue record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2025 came in at $1.94 million (Q3 2025), $2.61 million (Q2 2025) and $2.61 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn -
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn -
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn -
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn -
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn -
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Alumis 868.35 Mn -806.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.61 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 2.61 Mn
Mar 31, 2025 2.61 Mn
API Access

Alumis Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALMS&period=max&api_key=YOUR_API_KEY